BioCentury | Jul 14, 2008
Company News

Access Pharmaceuticals, MacroChem deal

...to treat hematological malignancies next quarter. MacroChem gained 4-thio Ara-C through its April acquisition of Virium Pharmaceuticals Inc....
BioCentury | Apr 28, 2008
Company News

MacroChem management update

...Infectious, Genitourinary Hired: James Pachence as CEO and a director, formerly president and CEO of Virium Pharmaceuticals Inc....
BioCentury | Apr 28, 2008
Company News

MacroChem, Virium deal

...treat diabetic foot infection. MacroChem also has SEPA, MacroDerm and DermaPass topical drug delivery technologies. Virium...
...OTCBB:MACM), Wellesley Hills, Mass. Virium Pharmaceuticals Inc. , Princeton, N.J. Business: Cancer, Infectious, Drug delivery MacroChem acquired Virium...
...the day before the deal closed. Each company's shareholders own 50% of the resulting company. Virium...
BioCentury | Sep 17, 2007
Company News

Virium, Southern Research Institute deal

...treat cancer. The institute will receive cash and Virium stock. Further terms were not disclosed. Virium Pharmaceuticals Inc....
Items per page:
1 - 4 of 4
BioCentury | Jul 14, 2008
Company News

Access Pharmaceuticals, MacroChem deal

...to treat hematological malignancies next quarter. MacroChem gained 4-thio Ara-C through its April acquisition of Virium Pharmaceuticals Inc....
BioCentury | Apr 28, 2008
Company News

MacroChem management update

...Infectious, Genitourinary Hired: James Pachence as CEO and a director, formerly president and CEO of Virium Pharmaceuticals Inc....
BioCentury | Apr 28, 2008
Company News

MacroChem, Virium deal

...treat diabetic foot infection. MacroChem also has SEPA, MacroDerm and DermaPass topical drug delivery technologies. Virium...
...OTCBB:MACM), Wellesley Hills, Mass. Virium Pharmaceuticals Inc. , Princeton, N.J. Business: Cancer, Infectious, Drug delivery MacroChem acquired Virium...
...the day before the deal closed. Each company's shareholders own 50% of the resulting company. Virium...
BioCentury | Sep 17, 2007
Company News

Virium, Southern Research Institute deal

...treat cancer. The institute will receive cash and Virium stock. Further terms were not disclosed. Virium Pharmaceuticals Inc....
Items per page:
1 - 4 of 4